{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Combination of a cholesterol biosynthesis inhibitor and a .beta.-lactam cholesterol absorption inhibitor", "item": "https://www.patentleaderboard.com/patent/5661145"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a cholesterol biosynthesis inhibitor and a .beta.-lactam cholesterol absorption inhibitor

Combination of a cholesterol biosynthesis inhibitor and a .beta.-lactam cholesterol absorption inhibitor

US Patent 5661145 · Granted Aug 26, 1997

Estimated economic value: $46,075,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating diabetes by administering a glucagon receptor antagonist in 2021
Use of azetidinone compounds2010
Use of substituted azetidinone compounds for the treatment of sitosterolemia2008
Use of azetidinone compounds2006
Methods and therapeutic combinations for the treatment of xanthoma using sterol 2006
Methods and therapeutic combinations for the treatment of diabetes using sterol 2006
Methods and therapeutic combinations for the treatment of obesity using sterol a2006
Substituted 2-azetidinones useful as hypocholesterolemic agents2006
Use of azetidinone compounds2005
Use of azetidinone compounds2003
Use of azetidinone compounds2003
Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents1998